Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 29, 2015 2:37 PM ET

Healthcare Equipment and Supplies

Company Overview of Corindus Vascular Robotics Inc.

Company Overview

Corindus Vascular Robotics Inc. provides designs, manufactures and sells precision vascular robotic-assisted systems for use in interventional vascular procedures. It offers CorPath 200 system, a robotic system that facilitates stent placement for percutaneous coronary intervention procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision. The company is based in Waltham, Massachusetts.

309 Waverley Oaks Road

Suite 105

Waltham, MA 02452

United States

62 Employees





Key Executives for Corindus Vascular Robotics Inc.

Chief Executive Officer, President and Director
Age: 55
Total Annual Compensation: $345.0K
Co-Founder and Executive Vice President Product and Business Development
Total Annual Compensation: $254.0K
Chief Financial Officer, Senior Vice President, Treasurer and Secretary
Age: 45
Total Annual Compensation: $286.0K
Compensation as of Fiscal Year 2014.

Corindus Vascular Robotics Inc. Key Developments

Corindus Vascular Robotics Inc.(AMEX:CVRS) added to Russell 2000 Index

Corindus Vascular Robotics Inc. will be added to Russell 2000 Index

Corindus Vascular Robotics Inc.(AMEX:CVRS) added to Russell 3000 Index

Corindus Vascular Robotics Inc. will be added to the Russell 3000 Index.

Corindus Vascular Robotics Inc. Initiates a Clinical Trial of its CorPath System in Peripheral Vascular Interventions

Corindus Vascular Robotics Inc. announced that it has initiated a clinical trial of its CorPath System in peripheral vascular interventions. The trial is a prospective, single-arm, single-center study that will enroll up to 20 patients. Researchers participating in the study will assess the safety and effectiveness of the CorPath System in recanalizing lower extremity arterial blockages during peripheral angioplasty procedures.

Similar Private Companies By Industry

Company Name Region
AVL Scientific Corporation United States
Kurve Technology, Inc. United States
Branchpoint Technologies, LLC United States
OrthoSensor, Inc. United States
STARR Life Sciences Corp. United States

Recent Private Companies Transactions

Private Placement
September 11, 2014
Private Placement
August 8, 2014
August 6, 2014
Your Internet Defender, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Corindus Vascular Robotics Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at